IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.5050
-0.0096 (-1.87%)
Oct 8, 2025, 11:50 AM EDT - Market open
IO Biotech Market Cap
IO Biotech has a market cap or net worth of $33.27 million as of October 8, 2025. Its market cap has decreased by -55.31% in one year.
Market Cap
33.27M
Enterprise Value
14.13M
1-Year Change
-55.31%
Ranking
Category
Stock Price
$0.51
Market Cap Chart
Since the IPO on November 5, 2021, IO Biotech's market cap has decreased from $369.28M to $33.27M, a decrease of -90.99%. That is a compound annual growth rate of -45.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 33.90M | -44.07% |
| Dec 31, 2024 | 60.61M | -51.06% |
| Dec 29, 2023 | 123.86M | 86.88% |
| Dec 30, 2022 | 66.28M | -64.06% |
| Dec 31, 2021 | 184.42M | -50.06% |
| Nov 5, 2021 | 369.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |